Brexucabtagen-Autoleucel
| Brexucabtagen-Autoleucel | |
|---|---|
| Term | Brexucabtagen-Autoleucel |
| Short definition | Brexucabtagen-Autoleucel - (pronounced) (brek-suh-KAB-tuh-jeen aw-toh-LOO-sel) A drug used to treat adults with mantle cell lymphoma or B-cell acute lymphoblastic leukemia that has come back or has not improved after other treatment. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Brexucabtagen-Autoleucel - (pronounced) (brek-suh-KAB-tuh-jeen aw-toh-LOO-sel) A drug used to treat adults with mantle cell lymphoma or B-cell acute lymphoblastic leukemia that has come back or has not improved after other treatment. It is also being studied in the treatment of other types of cancer. Brexucabtagene-Autoleucel is made using a patient's T cells (a type of cell in the immune system). A gene for a special receptor called the chimeric antigen receptor (CAR) is added to the T cells in the laboratory. Large numbers of these modified T cells, known as CAR T cells, are cultivated in the laboratory and given to the patient by infusion. Brexucabtagene autoleucel attaches to a protein called CD19, which is found on some lymphoma cells and leukemia cells. This helps the body's immune system kill cancer cells. Brexucabtagene Autoleucel is a form of CAR T cell therapy. Also called Tecartus
External links
- Medical encyclopedia article on Brexucabtagen-Autoleucel
- Wikipedia's article - Brexucabtagen-Autoleucel
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski